Although telomerase vaccines have proven to induce immune responses in blood, the T cell population expanded through vaccination is likely constrained by intrinsic and tumor-induced regulatory mechanisms, such as the checkpoint molecules CTLA-4 and PD-1/L1, respectively, and a varying degree of immunosuppression within the TME (depending on immunophenotype). Here, CTLA4 is linked to neoplasm.